selected publications
-
academic article
-
A fast and reliable DSC-based method to determine the monomolecular loading capacity of drugs with good glass-forming ability in mesoporous silica.
International Journal of Pharmaceutics.
544.
2018
Application of a Salt Coformer in a Co-Amorphous Drug System Dramatically Enhances the Glass Transition Temperature: A Case Study of the Ternary System Carbamazepine, Citric Acid, and l-Arginine..
Molecular Pharmaceutics.
15.
2018
Aspartame as a co-former in co-amorphous systems.
International Journal of Pharmaceutics.
549.
2018
Glass-Transition Temperature of the β-Relaxation as the Major Predictive Parameter for Recrystallization of Neat Amorphous Drugs..
The Journal of Physical Chemistry B.
122.
2018
Hot Melt Extrusion as Solvent-Free Technique for a Continuous Manufacturing of Drug-Loaded Mesoporous Silica.
Journal of Pharmaceutical Sciences.
107.
2018
In situ co-amorphisation of arginine with indomethacin or furosemide during immersion in an acidic medium – a proof of concept study.
European Journal of Pharmaceutics and Biopharmaceutics.
133.
2018
In vitro and in vivo comparison between crystalline and co-amorphous salts of naproxen-arginine.
European Journal of Pharmaceutics and Biopharmaceutics.
132.
2018
Influence of Solvent Composition on the Performance of Spray-Dried Co-Amorphous Formulations.
Pharmaceutics.
10.
2018
Influence of preparation technique on co-amorphization of carvedilol with acidic amino acids.
International Journal of Pharmaceutics.
552.
2018
Is there a correlation between the glass forming ability of a drug and its supersaturation propensity?.
International Journal of Pharmaceutics.
538.
2018
On the role of salt formation and structural similarity of co-formers in co-amorphous drug delivery systems.
International Journal of Pharmaceutics.
535.
2018
Organic acids as co-formers for co-amorphous systems - influence of variation in molar ratio on the physicochemical properties of the co-amorphous systems.
European Journal of Pharmaceutics and Biopharmaceutics.
131.
2018
Quantification of microwave-induced amorphization of celecoxib in PVP tablets using transmission Raman spectroscopy.
European Journal of Pharmaceutical Sciences.
117.
2018
Special issue on “Formulation strategies and manufacturing technologies to enhance non-invasive drug delivery”.
Asian Journal of Pharmaceutical Sciences.
13.
2018
The Influence of Polymers on the Supersaturation Potential of Poor and Good Glass Formers.
Pharmaceutics.
10.
2018
The Role of Glass Transition Temperatures in Coamorphous Drug-Amino Acid Formulations..
Molecular Pharmaceutics.
15.
2018
Undesired co-amorphisation of indomethacin and arginine during combined storage at high humidity conditions.
International Journal of Pharmaceutics.
544.
2018
Amorphization within the tablet: Using microwave irradiation to form a glass solution in situ.
International Journal of Pharmaceutics.
519.
2017
Cellulose Nanopaper and Nanofoam for Patient‐Tailored Drug Delivery.
Advanced Materials Interfaces.
4.
2017
Cellulose nanofibers as excipient for the delivery of poorly soluble drugs.
International Journal of Pharmaceutics.
533.
2017
Floating solid cellulose nanofibre nanofoams for sustained release of the poorly soluble model drug furosemide.
Journal of Pharmacy and Pharmacology.
69.
2017
Hot Melt Extrusion and Spray Drying of Co-amorphous Indomethacin-Arginine With Polymers.
Journal of Pharmaceutical Sciences.
106.
2017
Improvement of the physicochemical properties of Co-amorphous naproxen-indomethacin by naproxen-sodium.
International Journal of Pharmaceutics.
526.
2017
Influence of preparation pathway on the glass forming ability.
International Journal of Pharmaceutics.
521.
2017
Melt Extrusion of High-Dose Co-Amorphous Drug-Drug Combinations.
Pharmaceutical Research.
34.
2017
Performance comparison between crystalline and co-amorphous salts of indomethacin-lysine.
International Journal of Pharmaceutics.
533.
2017
Probing Pharmaceutical Mixtures during Milling: The Potency of Low-Frequency Raman Spectroscopy in Identifying Disorder..
Molecular Pharmaceutics.
14.
2017
Quantification of anaerobic thermophilic endospores in marine sediment by microcalorimetry, and its use in bioprospecting for gas and oil.
Limnology and Oceanography Methods.
15.
2017
Solid nanofoams based on cellulose nanofibers and indomethacin—the effect of processing parameters and drug content on material structure.
International Journal of Pharmaceutics.
526.
2017
Solid state properties and drug release behavior of co-amorphous indomethacin-arginine tablets coated with Kollicoat® Protect.
European Journal of Pharmaceutics and Biopharmaceutics.
119.
2017
Supersaturating drug delivery systems: The potential of co-amorphous drug formulations.
International Journal of Pharmaceutics.
532.
2017
The significance of the amorphous potential energy landscape for dictating glassy dynamics and driving solid-state crystallisation.
Physical Chemistry Chemical Physics.
19.
2017
Development of a screening method for co-amorphous formulations of drugs and amino acids.
European Journal of Pharmaceutical Sciences.
95.
2016
Glass Forming Ability of Amorphous Drugs Investigated by Continuous Cooling and Isothermal Transformation..
Molecular Pharmaceutics.
13.
2016
Glass solution formation in water - In situ amorphization of naproxen and ibuprofen with Eudragit® E PO.
Journal of Drug Delivery Science and Technology.
34.
2016
Influence of the cooling rate and the blend ratio on the physical stability of co-amorphous naproxen/indomethacin.
European Journal of Pharmaceutics and Biopharmaceutics.
109.
2016
Influence of variation in molar ratio on co-amorphous drug-amino acid systems.
European Journal of Pharmaceutics and Biopharmaceutics.
107.
2016
Investigation of physical properties and stability of indomethacin–cimetidine and naproxen–cimetidine co‐amorphous systems prepared by quench cooling, coprecipitation and ball milling.
Journal of Pharmacy and Pharmacology.
68.
2016
Preparation and characterization of spray‐dried co‐amorphous drug–amino acid salts.
Journal of Pharmacy and Pharmacology.
68.
2016
Preparation and recrystallization behavior of spray-dried co-amorphous naproxen–indomethacin.
European Journal of Pharmaceutics and Biopharmaceutics.
104.
2016
Properties of the Sodium Naproxen-Lactose-Tetrahydrate Co-Crystal upon Processing and Storage.
Molecules.
21.
2016
Recent advances and potential applications of modulated differential scanning calorimetry (mDSC) in drug development.
European Journal of Pharmaceutical Sciences.
87.
2016
Recent advances in co-amorphous drug formulations.
Advanced Drug Delivery Reviews.
100.
2016
Solid cellulose nanofiber based foams – Towards facile design of sustained drug delivery systems.
Journal of Controlled Release.
244.
2016
Solvent free amorphisation for pediatric formulations (minitablets) using mesoporous silica.
International Journal of Pharmaceutics.
511.
2016
The influence of co-formers on the dissolution rates of co-amorphous sulfamerazine/excipient systems.
International Journal of Pharmaceutics.
504.
2016
Characterization of Amorphous and Co-Amorphous Simvastatin Formulations Prepared by Spray Drying.
Molecules.
20.
2015
Comparative Study of Different Methods for the Prediction of Drug-Polymer Solubility..
Molecular Pharmaceutics.
12.
2015
Elucidating the Molecular Interactions Occurring during Drug Precipitation of Weak Bases from Lipid-Based Formulations: A Case Study with Cinnarizine and a Long Chain Self-Nanoemulsifying Drug Delivery System..
Molecular Pharmaceutics.
12.
2015
Evaluation of Drug–Polymer Solubility Curves Through Formal Statistical Analysis: Comparison of Preparation Techniques.
Journal of Pharmaceutical Sciences.
104.
2015
Formation Mechanism of Coamorphous Drug-Amino Acid Mixtures..
Molecular Pharmaceutics.
12.
2015
Improvement of dissolution rate of indomethacin by inkjet printing.
European Journal of Pharmaceutical Sciences.
75.
2015
Multivariate Quantification of the Solid State Phase Composition of Co-Amorphous Naproxen-Indomethacin.
Molecules.
20.
2015
Predicting Crystallization of Amorphous Drugs with Terahertz Spectroscopy..
Molecular Pharmaceutics.
12.
2015
Solid-state properties and dissolution behaviour of tablets containing co-amorphous indomethacin–arginine.
European Journal of Pharmaceutics and Biopharmaceutics.
96.
2015
Amino acids as co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability..
Molecular Pharmaceutics.
11.
2014
Improving co-amorphous drug formulations by the addition of the highly water soluble amino Acid, proline..
Pharmaceutics.
6.
2014
Refining stability and dissolution rate of amorphous drug formulations.
Expert Opinion on Drug Delivery.
11.
2014
The Influence of Pressure on the Intrinsic Dissolution Rate of Amorphous Indomethacin.
Pharmaceutics.
6.
2014
-
chapter
-
Stabilized Amorphous Solid Dispersions with Small Molecule Excipients.
Springer Nature.
2014
-
conference paper
-
hide from search
-
A theoretical and spectroscopic study of co-amorphous naproxen and indomethacin.
International Journal of Pharmaceutics.
2013
Amino acids as co-amorphous stabilizers for poorly water-soluble drugs – Part 2: Molecular interactions.
European Journal of Pharmaceutics and Biopharmaceutics.
2013
Emerging trends in the stabilization of amorphous drugs.
International Journal of Pharmaceutics.
2013
-
patent
-
A CELLULAR SOLID MATERIAL DRUG CARRIER COMPRISING CELLULOSE NANOFIBERS (CNF) WHEREIN THE CELLULAR SOLID MATERIAL COMPRISES CLOSED CELLS
2019
A CO-AMORPHOUS FORM OF A SUBSTANCE AND A DIPEPTIDE
2019
A CO-AMORPHOUS FORM OF A SUBSTANCE AND A PROTEIN
2019
A CO-AMORPHOUS FORM OF A SUBSTANCE AND A PROTEIN
2019
A CELLULAR SOLID MATERIAL DRUG CARRIER COMPRISING CELLULOSE NANOFIBERS (CNF) WHEREIN THE CELLULAR SOLID MATERIAL COMPRISES CLOSED CELLS
2018
A CO-AMORPHOUS FORM OF A SUBSTANCE AND A DIPEPTIDE
2018
A CO-AMORPHOUS FORM OF A SUBSTANCE AND A PROTEIN
2018
A CO-AMORPHOUS FORM OF A SUBSTANCE AND A PROTEIN
2018
SELF-ASSEMBLING STRUCTURES
2015